Skip to content
naulon

Not checkedNot checked for notices yet.

Aproximación al estudio del deterioro cognitivo en la esclerosis múltiple recurrente remitente. Un estudio en práctica clínica habitual empleando el Symbol Digit Modalities Test y la resonancia magnética convencional

D.A. García Estévez

Neurology Perspectives · 2021

doi:10.1016/j.neurop.2021.03.006 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Resumen: Introducción: El deterioro cognitivo es frecuente en la esclerosis múltiple (EM); se correlaciona con diferentes medidas de atrofia cerebral y tiene un impacto negativo en los ámbitos de la vida social, familiar y laboral. La manera de estudiar este deterioro cognitivo en la práctica clínica diaria implica emplear test simples como el Symbol Digit Modalities Test (SDMT) y obtener los datos de atrofia cerebral de una resonancia magnética (RM) convencional. Objetivo: Valorar el deterioro cognitivo (SDMT) y su correlación con medidas bidimensionales de atrofia cerebral en RM. Como medidas de atrofia se ha calculado el índice del cuerpo calloso (ICC) y la anchura del tercer ventrículo (A3V). Pacientes y métodos: Se estudiaron 113 pacientes con EM recurrente remitente procedentes de la consulta monográfica de EM. A todos los pacientes se les administró el SDMT y se calcularon el ICC y la A3V. Para las correlaciones se empleó la r de Pearson. Resultados: Las puntuaciones brutas del SDMT se correlacionaron significativamente (p < 0,001) con la edad (r = −0,58), la Expanded Disability Status Scale (r = −0,49), el ICC (r = 0,43) y la A3V (r = −0,57). Las medidas de atrofia cerebral en nuestro estudio mostraron una alta correlación entre ellas (r = −0,72, p < 0,0001). Al incluir la edad en las medidas de atrofia cerebral mejoraron las correlaciones: ICC/Edad (r = 0,63, p < 0,001) y A3V × Edad (r = −0,66, p < 0,001). Conclusiones: El SDMT es una buena herramienta de cribado del deterioro cognitivo en la EM y presenta una correlación moderada con la discapacidad y alta con las medidas de atrofia cerebral. Abstract: Introduction: Cognitive impairment is common in patients with multiple sclerosis (MS); it correlates with different measurements of brain atrophy and has a negative impact on social, family, and work activities. In clinical practice, cognitive impairment is studied with simple tests such as the Symbol Digit Modalities Test (SDMT) and through the acquisition of brain atrophy data with conventional magnetic resonance imaging (MRI). Objective: This study aimed to evaluate cognitive impairment (SDMT) and its correlation with two-dimensional measurements of brain atrophy in MRI studies. To measure atrophy, we calculated the corpus callosum index (CCI) and third ventricle width (TVW). Patients and methods: We studied 113 patients with relapsing-remitting MS from our centre's MS unit. All patients completed the SDMT, and CCI and TVW were calculated. The Pearson r statistic was used to analyse correlations. Results: Raw SDMT scores showed a significant correlation (P <.001) with age (r = –0.58), Expanded Disability Status Scale score (r = –0.49), CCI (r = 0.43), and TVW (r = –0.57). A strong correlation was observed between both measurements of brain atrophy (r = –0.72; P <.0001). When age was included in the analysis of brain atrophy, the correlations improved: CCI/age (r = 0.63; P <.001) and TVW x age (r = –0.66; P <.001). Conclusions: The SDMT is useful in screening for cognitive impairment in patients with MS, and presents a moderate correlation with disability and a strong correlation with measurements of brain atrophy.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.